Stories of Impact
Jamie Racklyeft
University of Michigan Receives $71M NIH Grant ...

MICHR to tackle goal of diversifying and improving research to speed therapies for benefit of all patients

University of Michigan Receives $71M NIH Grant to Advance Clinical & Translational Science
Engaging Communities
Jamie Racklyeft
Dr. Polly Gipson Named Community Engagement ...

Polly Y. Gipson, PhD, is our new Community Engagement Faculty Director. Dr. Gipson was selected following a university-wide search, including four rounds of interviews with staff, faculty, and community partners.

COVID-19, Stories of Impact
Nicole Bonomini
Existing Drugs Kill SARS-CoV-2 in Cells

A new groundbreaking study from the University of Michigan’s Center for Drug Repurposing (CDR) reveals several drug contenders already in use for other purposes—including one dietary supplement—that have been shown to block or reduce SARS-CoV-2 infection in cells.

The study, published recently in the Proceedings of the National Academy of Sciences, uses artificial intelligence-powered image analysis of human cell lines during infection with the novel coronavirus.

MICHR Funding, Funding & Grant Writing
Nicole Bonomini
Apply Now for MICHR $100,000 Accelerating ...

Are you interested in positioning your interdisciplinary research team to be competitive for an external large-scale grant (e.g., NIH U- and P-series mechanisms)? If so, you’re encouraged to apply for $100,000 in funding and tailored research support available through the Accelerating Synergy Award.

Regulatory Support (MIAP)
Nicole Bonomini
Do Your Patients Need Access to Investigational ...

In an effort to make access to experimental agents easier and more efficient, Transforming Expanded Access to Maximize Support and Study (TEAMSS) has published new recommended guidelines, templates, and resources for physicians and institutions seeking Expanded Access for their patients.

Regulatory Support (MIAP)

Do Your Patients Need Access to Investigational Drugs, Biologics, or Medical Devices Through FDA’s Expanded Access Pathway?

In an effort to make access to experimental agents easier and more efficient, Transforming Expanded Access to Maximize Support and Study (TEAMSS) has published new recommended guidelines, templates, and resources for physicians and institutions seeking Expanded Access for their patients.

,

MICHR Enables U-M Physicians to Request Remdesivir Through Expanded Access

,

Since MICHR was awarded the Transforming Expanded Access to Maximize Support and Study (TEAMSS) grant two years ago, the consortium of universities involved in TEAMSS has worked to develop and test infrastructure, best practices, and reduce burdensome data collection for expanded access that will allow other academic medical centers to become more effective and efficient in supporting these requests.

,

Working on a COVID-related drug or device project? Consult with MIAP

,

As the coronavirus pandemic began spreading to the U.S., the U-M research community responded with many innovative ideas to treat patients, prevent infections, and address shortages of medical products. MICHR’s MIAP, which supports investigator-initiated clinical trials with FDA submissions, became the first stop in the research project lifecycle for COVID-19 research ideas involving drugs or devices.